NICORANDIL DERIVATE
Patent europeic · EP3937938 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP3937938
- Numer da la dumonda
- EP20720153
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 16-03-2020
- Publitgà
- 19-01-2022
- Concedì
- 28-01-2026
- Stritgà
- 23-10-2026
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- A61K 31/455 (2006.01)A61P 13/12 (2006.01)
- Prioritad
- US 201962819372 P 15.03.2019
- Dumonda PCT
- PCT/US2020/023016 16.03.2020
- Publicaziun PCT
- WO2020/190890 24.09.2020
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 23-10-2026
Stritgà, taxa betg pajada
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2026
- 30-04-2026
Owner
- Owner
- Unicycive Therapeutics Inc., 4300 El Camino Real, Suite 210, Los Altos, CA 94022, USA → Unicycive Therapeutics Inc., 1975 W. El Camino Real, Suite 204, Mountain View, CA 94040, USA
Published in Swissreg on 30.04.2026
- 28-01-2026
Concedì
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 28.01.2026
Partidas
Possessur
Unicycive Therapeutics Inc.
Mountain View, CA 94040, US
Inventur
GUPTA, Shalabh
Mountain View, CA 94040, US
DUGAR, Sundeep
San Jose, CA 95120, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.